THRM Gentherm Inc
XNAS
28.44
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $27.00 – $48.35
- YTD
- -22.78%
- IV Rank (30D)
- 100.0
- Straddle Price
- $4.88
- P/C Vol Ratio
- 1.05
- Market Cap
- $1.6B
- Open
- $29.39
- Day Range
- $27.92 – $29.43
- Volume
- 1,627,966
- Prev Close
- $29.27
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.05 |
| Cost of Equity (CAPM) | 10.94% (VRP-adj) |
| WACC | 9.63% |
| Volatility Risk Premium | +42.8pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +7.6% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.08 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 3.7% |
| Book / Price | 82.4% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 24.0% |
| FCF Margin (TTM) | 2.6% |
| Debt / Equity | 0.38 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +13.6% (reverse-DCF on current price) |
| SMA 50 | $36.23 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $31.29 |
| Bollinger Width / SMA20 | 80.4% (drives anchor stability) |
| Net Debt | $0.1B |
| Market Cap | $1B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $21.85 | 34% | |
| DDM (Gordon) | $36.60 | 0% | |
| Peer P/E | $13.27 | 8% | median 14.3× · 6 peers |
| Peer EV/EBITDA | $26.22 | 10% | median 6.0× · 6 peers |
| Peer P/B | $33.96 | 13% | median 1.4× · 7 peers |
| Peer P/S | $27.52 | 13% | median 0.5× · 7 peers |
| Market Anchor (SMA50) | $36.23 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $28.38 | 21% | 12 strikes · skew +0.15 |
- Industry (SIC)
- MOTOR VEHICLE PARTS & ACCESSORIES (3714) · industry map
- Exchange
- XNAS
- Market Cap
- $1.6B
- Employees
- 14,174
- List Date
- 1993-06-10
- CIK
- 0000903129
- Next Earnings
- 2026-10-22 (Pre-Market)
- EPS Forecast
- $0.66 (6 est.)
- Headquarters
- Novi, MI
- Homepage
- https://www.gentherm.com
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other …
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -3.47% | -0.35% | 13.03% | -7.63% | -3.00% | -13.22% | -2.44% |
| Feb | 10.80% | -4.11% | -15.63% | 15.29% | -8.62% | 2.73% | 0.08% |
| Mar | -3.30% | -9.14% | -6.00% | -0.23% | -15.65% | -14.01% | -8.05% |
| Apr | -7.77% | -6.75% | 0.32% | -9.79% | -2.44% | 6.51% | -3.32% |
| May | -1.39% | 0.16% | -7.49% | 3.89% | 3.66% | 14.49% | 2.22% |
| Jun | -5.11% | -8.60% | 2.23% | -10.07% | 8.98% | -4.13% | -2.78% |
| Jul | 15.42% | 2.69% | 3.98% | 10.25% | 7.77% | 18.12% | 9.71% |
| Aug | 2.18% | -6.33% | -8.86% | -6.58% | 15.59% | -5.39% | -1.56% |
| Sep | -7.15% | -15.77% | -10.17% | -4.45% | -6.22% | -13.78% | -9.59% |
| Oct | -11.70% | 11.13% | -26.16% | -6.38% | 7.67% | -15.43%* | -6.81% |
| Nov | 9.25% | 19.98% | 17.14% | -2.70% | -4.88% | -- | 7.76% |
| Dec | 1.51% | -10.16% | 13.48% | -6.46% | 0.55% | -- | -0.22% |
| Total | -4.29% | -28.07% | -28.93% | -24.91% | -0.87% | -26.97% | -19.01% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
SYMBOL: THRM
Executive Summary: This report is NEUTRAL with a confidence level of 6/10. Key drivers include recent positive news headlines, stabilizing technical indicators, and moderate volatility. Primary risks are the stock's historical high volatility and the potential for negative earnings surprises.
Investment thesis: Gentherm's (THRM) recent acquisitions and FDA clearances have strengthened its medical product portfolio and customer channels. While the company faces moderate risk due to its high beta and volatile price action, it has demonstrated a trend of stabilizing technical indicators. The stock is trading near its 50-day moving average, indicating a potential short-term buying opportunity.
Recent news sentiment impact: The recent positive news headlines have had a bullish impact on THRM's stock price, driving the stock higher over the past few days.
Technical Analysis:
Trend Direction: Short-term (1-4 weeks): Uptrend; Medium-term (1-3 months): Sideways trend; Long-term (3-12 months): Downtrend
Support/Resistance Levels:
- Lower support level: $38.89
- Upper resistance level: $43.83
Momentum Signals: RSI (14) is at 45.96, indicating a neutral momentum signal.
MACD: The MACD has crossed above the signal line, indicating a bullish momentum signal.
Bollinger Bands: The stock is trading in the middle of its Bollinger Bands, indicating a neutral momentum signal.
Volume Analysis: Volume has been decreasing over the past few days, suggesting a potential reversal in momentum.
News & Sentiment Analysis:
Recent Headlines Summary: THRM has received positive news headlines regarding acquisitions and FDA clearances, which have driven the stock higher.
Sentiment Assessment: The aggregate sentiment is POSITIVE due to recent news headlines.
Catalyst Identification: Upcoming earnings release (no specific date available).
Market Narrative: The recent positive news has aligned with technical signals, indicating a potential buying opportunity.
Risk & Volatility Assessment:
Beta Interpretation: THRM's beta is 1.09, indicating above-average volatility relative to the market.
Volatility Regime: The stock is currently experiencing moderate volatility.
Options Market Signals: IV rank is 50.7%, indicating medium volatility expectations.
Downside Protection: Support levels at $38.89 and risk management considerations suggest a potential stop-loss level around $39.10.
Market Context & Positioning:
Sector Performance: THRM's sector (Healthcare) has been performing well, with an R-squared value of 0.71.
Institutional Activity: Institutional interest is moderate, with a put/call ratio of 2.46 and open interest in calls at 140 and puts at 394.
Correlation Analysis: THRM's correlation coefficient is 0.31 with the market (SPY), indicating an inverse relationship.
Relative Valuation: The stock is trading near its 50-day moving average, suggesting a potential buying opportunity.
Key Levels & Action Items:
- Critical price levels: Support at $38.89 and resistance at $43.83
- Breakout/breakdown levels: Above $40.66 for an uptrend or below $38.81 for a downtrend
- Time-sensitive catalysts: Earnings release (no specific date available)
- Risk management: Stop-loss level around $39.10
This report provides a comprehensive analysis of THRM, highlighting recent positive news headlines, stabilizing technical indicators, and moderate volatility. The stock is trading near its 50-day moving average, suggesting a potential buying opportunity. However, the company faces above-average volatility and potential negative earnings surprises, making it essential to monitor these risks closely.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2022-02-17 | Pre-Market | 6.98% | 0.24% | 0.03x | Within |
| 2023-10-26 | Pre-Market | 8.85% | 15.58% | 1.76x | Exceeded |
| 2024-02-21 | Pre-Market | 8.28% | 20.04% | 2.42x | Exceeded |
| 2024-04-30 | Pre-Market | 10.74% | 0.38% | 0.04x | Within |
| 2024-07-31 | Pre-Market | 9.99% | 9.68% | 0.97x | Within |
| 2024-10-30 | After-Close | 12.14% | 0.59% | 0.05x | Within |
| 2025-02-19 | Pre-Market | 7.68% | 7.75% | 1.01x | Exceeded |
| 2025-04-24 | After-Close | 22.23% | 0.00% | 0.00x | Within |
| 2025-07-24 | Pre-Market | 16.41% | 2.72% | 0.17x | Within |
| 2025-10-23 | Pre-Market | 12.23% | 8.18% | 0.67x | Within |
| 2026-02-19 | Pre-Market | 15.85% | 1.29% | 0.08x | Within |
| 2026-04-23 | Pre-Market | 17.83% | 2.99% | 0.17x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
THRM Options Activity & IV Rank
THRM IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 10th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Above average volatility - stock moves with market amplification
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $9.8M | #1602 of 6285 | +35.8% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $6.0M | #1352 of 3138 | -35.2% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $351K | #3307 of 3716 | -94.1% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $25K | #3665 of 4729 | -5.3% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
THRM Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | PEAK6 LLC | $1.71M | 85.91% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $279.70K | 14.09% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $951.67K | 100.00% | 2026-06-30 |
THRM Insider Trading (Form 4)
Latest: 2026-10-06| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Paul Anthony Mascarenas | Director | Award (A) | +2,677 | — | EDGAR | |
| 2026-08-18 | Breisacher Nicholas | Chief Accounting Officer | Sell (S) | −925 | $43.21 | -$40.0K | EDGAR |
| 2026-07-30 | Wayne S Kauffman III | SVP and General Counsel | Sell (S) | −4,700 | $43.21 | -$203.1K | EDGAR |
| 2026-05-15 | Elizabeth Meter | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | Laura Michele Kowalchik | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | Sophie Desormiere | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | Ronald T Hundzinski | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | Charles R. Kummeth | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | John Stacey | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | Kenneth E Washington | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-05-15 | David W Heinzmann | Director | Award (A) | +4,292 | — | EDGAR | |
| 2026-03-25 | Jaymi Wilson | SVP, Chief Strategy Officer | Mixed | +1,764 | $28.64 | -$20.3K | EDGAR |
| 2026-03-25 | Chenglong Wang | VP & General Manager | Award (A) | +266 | — | EDGAR | |
| 2026-03-25 | Rafael Barkas | SVP Global Ops & Supply Chain | Mixed | +1,514 | $28.64 | -$17.4K | EDGAR |
| 2026-03-25 | Barbara J Runyon | SVP, CHRO | Mixed | +1,160 | $28.64 | -$27.5K | EDGAR |
THRM Insider Holdings
21 insiders · @ $28.44| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | William T. Presley | President & CEO | 178,314 | $5.07M | $74.0K | 6 | 2026-03-18 |
| 2 | Phillip Eyler | President & CEO | 139,663 | $3.97M | -$13.68M | 32 | 2025-02-25 |
| 3 | Jonathan C Douyard | EVP, CFO, Treasurer | 69,639 | $1.98M | $0 | 5 | 2026-03-18 |
| 4 | Jaymi Wilson | SVP, Chief Strategy Officer | 42,726 | $1.22M | $0 | 20 | 2026-03-25 |
| 5 | Sophie Desormiere | Director | 42,303 | $1.20M | $0 | 14 | 2026-05-15 |
| 6 | Ronald T Hundzinski | Director | 40,263 | $1.15M | $202.2K | 13 | 2026-05-15 |
| 7 | Barbara J Runyon | SVP, CHRO | 37,686 | $1.07M | -$410.7K | 29 | 2026-03-25 |
| 8 | Rafael Barkas | SVP Global Ops & Supply Chain | 31,893 | $907.0K | -$627.0K | 29 | 2026-03-25 |
| 9 | Vishnu Sundaram | SVP, Chief Technology Officer | 28,473 | $809.8K | $0 | 7 | 2026-03-18 |
| 10 | Thomas Stocker | President, Gentherm Tech. | 28,085 | $798.7K | -$634.7K | 25 | 2026-03-25 |
THRM Board & Officers
As of SEC filings through Oct 6, 2026Directors 10
- Sophie Desormiere · since May 10, 2012
- Ronald T Hundzinski · since May 26, 2016
- John Stacey · since May 18, 2018
- Charles R. Kummeth · since Aug 1, 2018
- David W Heinzmann · since Aug 11, 2020
- Elizabeth Meter · since Jan 8, 2021
- Kenneth E Washington · since Oct 2, 2023
- Laura Michele Kowalchik · since Dec 1, 2023
- William T. Presley · since Jan 1, 2025
- Paul Anthony Mascarenas · since Oct 1, 2026
Officers 6
- William T. Presley · President & CEO · since Jan 1, 2025
- Jonathan C Douyard · EVP, CFO, Treasurer · listed since Feb 2025
- Breisacher Nicholas · Chief Accounting Officer · since Aug 5, 2022
- Wayne S Kauffman III · SVP and General Counsel · listed since Jun 2021
- Barbara J Runyon · SVP, CHRO · listed since Mar 2024
- Thomas Stocker · SVP, General Manager, Europe · listed since Mar 2024
Changes in the last 10 years (61)
| Oct 1, 2026 | Paul Anthony Mascarenas became a director |
| Apr 6, 2026 | Vishnu Sundaram reported in an SEC filing no longer being SVP, Chief Technology Officer |
| Mar 25, 2026 | Rafael Barkas reported in an SEC filing no longer being SVP, Global Ops & Supply Chain |
| Mar 25, 2026 | Jaymi Wilson reported in an SEC filing no longer being SVP, General Manager NA |
| Mar 25, 2026 | Chenglong Wang reported in an SEC filing no longer being VP & General Manager |
| Feb 25, 2025 | Phillip Eyler reported in an SEC filing no longer being a director |
| Feb 25, 2025 | Phillip Eyler reported in an SEC filing no longer being President & CEO |
| Feb 25, 2025 | Jonathan C Douyard listed as EVP, CFO, Treasurer (previously Chief Financial Officer) in SEC filings |
| Jan 1, 2025 | William T. Presley became a director |
| Jan 1, 2025 | William T. Presley became President & CEO |
| Jan 1, 2025 | Jonathan C Douyard became Chief Financial Officer |
| Dec 14, 2024 | Chenglong Wang became VP & General Manager |
| Aug 5, 2024 | The company announced the departure of Matteo Anversa as EVP, CFO, Treasurer in an SEC filing |
| Mar 26, 2024 | Jaymi Wilson listed as SVP, General Manager NA (previously Senior Vice President) in SEC filings |
| Mar 18, 2024 | Vishnu Sundaram listed as SVP, Chief Technology Officer (previously Chief Technology Officer) in SEC filings |
| Mar 13, 2024 | Thomas Stocker listed as SVP, General Manager, Europe (previously SVP, GM Glo Pneu Comf & BPS) in SEC filings |
| Mar 13, 2024 | Matteo Anversa listed as EVP, CFO, Treasurer (previously Ex VP, CFO & Treasurer) in SEC filings |
| Mar 13, 2024 | Jaymi Wilson listed as Senior Vice President (previously SVP, GM Glo Sales & Glo Mktg) in SEC filings |
| Mar 13, 2024 | Hui (Helen) Xu listed as SVP, General Manager, Asia (previously SVP, GM Climate & Comfort) in SEC filings |
| Mar 13, 2024 | Barbara J Runyon listed as SVP, CHRO (previously SVP, CHRO & Corp Comm) in SEC filings |
| Dec 1, 2023 | Laura Michele Kowalchik became a director |
| Oct 2, 2023 | Kenneth E Washington became a director |
| Sep 5, 2023 | Vishnu Sundaram became Chief Technology Officer |
| Mar 14, 2023 | Thomas Stocker listed as SVP, GM Glo Pneu Comf & BPS (previously SVP, GM Digital Interior & BPS) in SEC filings |
| Mar 14, 2023 | Jaymi Wilson listed as SVP, GM Glo Sales & Glo Mktg (previously SVP, Global Sales) in SEC filings |
| Mar 14, 2023 | Barbara J Runyon listed as SVP, CHRO & Corp Comm (previously SVP & CHRO) in SEC filings |
| Jan 25, 2023 | The company announced the departure of Matthew Fisch as SVP & Chief Technology Officer in an SEC filing |
| Jan 16, 2023 | The company announced the departure of Yvonne Hao from the board in an SEC filing |
| Aug 5, 2022 | Breisacher Nicholas became Chief Accounting Officer |
| Jul 7, 2022 | The company announced the departure of Jennifer L. Zoldos as Chief Accounting Officer in an SEC filing |
| Mar 15, 2022 | Thomas Stocker listed as SVP, GM Digital Interior & BPS (previously SVP & GM Automotive) in SEC filings |
| Mar 15, 2022 | Hui (Helen) Xu listed as SVP, GM Climate & Comfort (previously SVP & GM Electronics) in SEC filings |
| Oct 12, 2021 | Yijing Brentano listed as SVP, Strategy, Corp Dev & IR (previously Senior VP IR and FPA) in SEC filings |
| Oct 1, 2021 | Jaymi Wilson became SVP, Global Sales |
| Jun 23, 2021 | Wayne S Kauffman III listed as SVP and General Counsel (previously VP and General Counsel) in SEC filings |
| Jan 8, 2021 | Elizabeth Meter became a director |
| Aug 11, 2020 | David W Heinzmann became a director |
| Jun 22, 2020 | Jennifer L. Zoldos became Chief Accounting Officer |
| Apr 6, 2020 | Matthew Fisch became SVP & Chief Technology Officer |
| Mar 16, 2020 | Thomas Stocker listed as SVP & GM Automotive (previously SVP and General Manager) in SEC filings |
| Mar 16, 2020 | Phillip Eyler listed as President & CEO (previously Chief Executive Officer) in SEC filings |
| Mar 16, 2020 | Paul Cameron Giberson listed as SVP Global Sales (previously Sr. VP Sales) in SEC filings |
| Mar 16, 2020 | Hui (Helen) Xu listed as SVP & GM Electronics (previously SVP and General Manager) in SEC filings |
| Mar 16, 2020 | Barbara J Runyon listed as SVP & CHRO (previously Chief Human Resources Officer) in SEC filings |
| Feb 27, 2020 | Yijing Brentano listed as Senior VP IR and FPA (previously Senior VP IR and Corp Comm) in SEC filings |
| Feb 26, 2020 | Rafael Barkas became SVP, Global Ops & Supply Chain |
| Nov 4, 2019 | Hui (Helen) Xu became SVP and General Manager |
| Sep 1, 2019 | Thomas Stocker became SVP and General Manager |
| Jul 1, 2019 | Wayne S Kauffman III became VP and General Counsel |
| Jan 2, 2019 | Matteo Anversa became Ex VP, CFO & Treasurer |
| Nov 16, 2018 | Paul Cameron Giberson became Sr. VP Sales |
| Nov 11, 2018 | Mark A Potesta became Sr. VP and CTO |
| Aug 13, 2018 | Barbara J Runyon became Chief Human Resources Officer |
| Aug 1, 2018 | Charles R. Kummeth became a director |
| Jul 30, 2018 | Ryan Wesley Gaul listed as VP Operations (previously VP Strategy) in SEC filings |
| May 18, 2018 | John Stacey became a director |
| May 9, 2018 | Ryan Wesley Gaul listed as VP Strategy (previously VP Business Development) in SEC filings |
| Apr 12, 2018 | Yijing Brentano became Senior VP IR and Corp Comm |
| Dec 4, 2017 | Phillip Eyler became a director |
| Dec 4, 2017 | Phillip Eyler became Chief Executive Officer |
| Feb 27, 2017 | Darren Schumacher listed as Pres. Gentherm Technologies (previously VP Product Development) in SEC filings |
- Prev
- 1
Not reported recently (15)
- Hui (Helen) Xu · Last reported as SVP, General Manager, Asia in an SEC filing dated Dec 5, 2024
- Yijing Brentano · Last reported as SVP, Strategy, Corp Dev & IR in an SEC filing dated Jun 4, 2024
- Byron Shaw · Last reported as a director in an SEC filing dated May 22, 2023
- Paul Cameron Giberson · Last reported as SVP Global Sales in an SEC filing dated Aug 4, 2021
- Kenneth John Phillips · Last reported as VP & General Counsel/Secretary in an SEC filing dated Jun 24, 2019
- Frithjof Oldorff · Last reported as President Auto BU in an SEC filing dated Jun 12, 2019
- Ryan Wesley Gaul · Last reported as VP Operations in an SEC filing dated Jun 12, 2019
- Francois J Castaing · Last reported as a director in an SEC filing dated May 17, 2019
- Maurice EP Gunderson · Last reported as a director in an SEC filing dated May 17, 2019
- Mark A Potesta · Last reported as Sr. VP and CTO in an SEC filing dated Feb 27, 2019
- Barry G Steele · Last reported as CFO/VP Finance/Treasurer in an SEC filing dated Dec 21, 2018
- Darren Schumacher · Last reported as Pres. Gentherm Technologies in an SEC filing dated Feb 26, 2018
- Erin Erwine Ascher · Last reported as VP Talent Devlopment CHRO in an SEC filing dated Feb 26, 2018
- Daniel R Coker · Last reported as President & CEO in an SEC filing dated Dec 4, 2017
- Lewis W K Booth · Last reported as a director in an SEC filing dated May 22, 2017
THRM Proposed Insider Sales (Form 144)
Latest: 2026-08-17What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | Nicholas William Breisacher | Officer | 925 | $40.0K | 2026-08-17 | Merrill Lynch | — | EDGAR |
| 2026-07-29 | Wayne Kauffman | Officer | 4,700 | $202.8K | 2026-07-29 | Merrill Lynch | — | EDGAR |
| 2025-08-21 | Runyon Barbara J | Officer | 3,348 | $116.4K | 2025-08-21 | Merrill | — | EDGAR |
| 2024-12-11 | Stocker Thomas | Officer | 1,295 | $55.7K | 2024-12-11 | Merrill Lynch | — | EDGAR |
| 2024-12-05 | Xu Hui (Helen) | Officer | 2,500 | $105.0K | 2024-12-05 | Merrill Lynch | — | EDGAR |
| 2024-11-29 | Barkas Rafael | Officer | 2,914 | $122.8K | 2024-11-29 | Merrill Lynch | — | EDGAR |
| 2024-11-21 | Eyler Phillip | Officer | 29,684 | $1.26M | 2024-11-21 | MERRILL LYNCH | 10b5-1 | EDGAR |
| 2024-09-17 | Eyler Phillip | Officer | 15,000 | $750.0K | 2024-09-17 | MERRILL LYNCH | 10b5-1 | EDGAR |
| 2024-08-06 | Eyler Phillip | Officer | 15,000 | $750.5K | 2024-08-06 | MERRILL LYNCH | 10b5-1 | EDGAR |
| 2024-07-11 | Eyler Phillip | Officer | 15,000 | $756.0K | 2024-07-11 | MERRILL LYNCH | 10b5-1 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.09% | $94.9M | $103.1B | 2026-10-20 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.05% | $38.7M | $75.1B | 2026-10-20 |
| 3 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $30.8M | — | 2026-09-30 |
| 4 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.10% | $30.4M | $31.4B | 2026-10-20 |
| 5 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.01% | $21.9M | — | 2026-09-30 |
| 6 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.06% | $15.8M | — | 2026-10-20 |
| 7 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.09% | $14.5M | $15.7B | 2026-10-20 |
| 8 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.02% | $14.2M | — | 2026-09-30 |
| 9 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $11.6M | — | 2026-09-30 |
| 10 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.03% | $10.9M | — | 2026-10-20 |
| 11 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.03% | $9.3M | — | 2026-10-20 |
| 12 | PBW Invesco WilderHill Clean Energy ETF | Nport | 2.07% | $8.7M | — | 2026-07-31 |
| 13 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.06% | $8.4M | $13.7B | 2026-10-20 |
| 14 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.10% | $7.4M | $7.6B | 2026-10-20 |
| 15 | IJT iShares S&P Small-Cap 600 Growth ETF | iShares (BlackRock) | 0.09% | $6.5M | $7.6B | 2026-10-20 |
| 16 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.05% | $6.5M | $13.6B | 2026-10-20 |
| 17 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.03% | $6.0M | — | 2026-09-30 |
| 18 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.06% | $5.7M | — | 2026-05-31 |
| 19 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $5.1M | — | 2026-05-31 |
| 20 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.01% | $4.9M | — | 2026-10-20 |
| 21 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.10% | $4.6M | $4.7B | 2026-10-20 |
| 22 | BSVO EA Bridgeway Omni Small-Cap Value ETF | Nport | 0.17% | $4.1M | — | 2026-06-30 |
| 23 | SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF | SPDR (State Street) | 0.09% | $4.0M | $4.6B | 2026-10-20 |
| 24 | VCR Vanguard Consumer Discretionary ETF | Vanguard | 0.06% | $3.8M | — | 2026-09-30 |
| 25 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.06% | $3.6M | — | 2026-09-30 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $416.17M | $4.42M | $0.14 | $7.32M |
| Q1 '26 | 2026-03-31 | $393.71M | $4.22M | $0.14 | $-5.04M |
| Q4 '25 | 2025-12-31 | $382.79M | $2.99M | $0.09 | $28.97M |
| Q3 '25 | 2025-09-30 | $386.87M | $14.95M | $0.49 | $56.12M |
| Q2 '25 | 2025-06-30 | $375.09M | $477.00K | $0.02 | $45.05M |
| Q1 '25 | 2025-03-31 | $353.85M | $-128.00K | — | $-13.34M |
| Q4 '24 | 2024-12-31 | $352.91M | $15.32M | $0.49 | $36.56M |
| Q3 '24 | 2024-09-30 | $371.51M | $15.96M | $0.51 | $46.27M |
| Q2 '24 | 2024-06-30 | $375.68M | $18.88M | $0.60 | $37.15M |
| Q1 '24 | 2024-03-31 | $356.01M | $14.79M | $0.47 | $-10.32M |
| Q4 '23 | 2023-12-31 | $366.93M | $18.09M | $0.55 | $39.22M |
| Q3 '23 | 2023-09-30 | $366.19M | $15.84M | $0.48 | $21.43M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.